TiH researcher Celine van de Laar presented her findings on the cost-effectiveness of a JAK1/JAK2-inhibitor versus a biological DMARD in rheumatoid arthritis patients at the Annual European Congress of Rheumatology in Madrid, Spain.
Transparency in Healthcare (TiH) is dedicated to improving the transparancy and quality of healthcare through innovative information technology and state-of-the-art outcomes research.
We develop tailored and user-friendly online monitoring software systems that allow to prospectively and systematically register real-world patient data. Our team has specific scientific expertise in the development and application of innovative patient-reported outcome measurement tools. We provide consulting services and operational capabilities in conducting and reporting real-world health outcomes research.
CAT Physical FunctioningTiH has developed a new Computerized Adaptive Test for physical functioning.
Try the demo here »
Article about the development of the common metric for comparing the 10 most frequently used physical function PROMs in rheumatology published in Quality of Life Research.
International jury awards prestigious prize for our use of innovative technology to ease implementation of VBHC.
This week ICHOM released the standard set of outcomes for inflammatory arthritis. These outcomes are recommended for measuring and reporting the results of treatment that patients experience.
Customized online software solutions for collecting real-world data on health care outcomes.
Combining clinical measures with PROMs to provide a holistic view on the quality of healthcare.
Innovative methods for smart and efficient assessment of patient-reported outcomes.
Standardization of outcomes by scaling different instruments on the same metric.
Consultation and operational support for real-world health outcomes research.